Show results for
Refine by
Liquid Biopsy Technology Equipment Supplied In Usa
5 equipment items found
Manufactured by:Kailos Genetics, LLC. based inHuntsville, ALABAMA (USA)
Kailos Iota combines TargetRich, our foundational genetic enrichment technology, with next-generation sequencing and statistical machine learning that results in a highly specific cancer assay of multiple solid tumors at all stages. The Iota assay detects methylation differences in a person’s blood sample, the superior choice for early disease detection. The process of ...
Manufactured by:Nucleix Ltd. based inSan Diego, CALIFORNIA (USA)
Liquid biopsies are a new powerful tool in cancer diagnostics that is transforming patient healthcare. Body fluids such as blood or urine are obtained from the patient and analyzed for the presence of circulating tumor DNA which is shed from the cancer. This DNA can tell if cancer is present, its type, effective medications, and more. Liquid biopsies can offer a non-invasive and cost-effective ...
by:NeoGenomics Laboratories based inFort Myers, FLORIDA (USA)
RaDaR™ is a personalized, multi-tumor liquid biopsy assay that can track a set of up to 48 tumor-specific variants in a patient using a liquid biopsy with exceptional sensitivity. This allows RaDaR™ to detect traces of molecular residual disease (MRD) in a patient following surgery or other treatment for cancer, enabling early detection of relapse and accurate monitoring. ...
Manufactured by:INOVIQ Ltd based inNotting Hill, AUSTRALIA
INOVIQ’s NETs technology is a sample preparation platform with the potential to revolutionise the performance of liquid biopsy diagnostic assays. The market potential for liquid biopsy applications is estimated at billions of dollars ...
Manufactured by:INOVIQ Ltd based inNotting Hill, AUSTRALIA
EXO-NET RUO - a pan-exosome capture tool for isolation of exosomes from body fluids including plasma, urine, and saliva. Exosomes are small membrane-enclosed vesicles actively secreted by most cells into biological fluids including serum, plasma, urine, breast milk, and saliva [1]. Studies have found that the analysis of exosome-associated nucleic acids, proteins and/or lipids can indicate the ...